openPR Logo
Press release

Anti-Inflammatory Biologics Market to Register a CAGR of 11.0% till 2027; Increasing Prevalence of Rheumatoid Arthritis to Create Sales Opportunities, states Fortune Business Insights™

03-31-2022 08:21 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Anti-Inflammatory Biologics Market

Anti-Inflammatory Biologics Market

The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled "Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027" the market size stood at USD 64.84 billion in 2019.

Get Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/sample/anti-inflammatory-biologics-market-102733

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Geographical Analysis:
• North America (The U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• The Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)
Market Driver:

Ongoing Trails for Anti-Tumour Necrosis Factor Therapy to Benefit COVID-19 Patients
The increasing R&D investments by major players for the development of biologics will promote market growth in the forthcoming years. The rising number of deaths from coronavirus (COVID-19) has steered pharmaceutical companies to invest in potential drug candidates. The growing prominence of TNF in acute inflammatory reactions will have a positive impact on the market. Similarly, the ongoing research for anti-TNF therapy in patients with COVID-19 for counteraction and prevention will tremendously influence the market in the forthcoming years.

Moreover, the advent of novel biological therapies and monoclonal antibodies by biopharma giants will facilitatethe healthy growth of the marketduring the forecast period. For instance, in December 2019, UCB S.A, a multinational biopharmaceutical company announced positive results from the phase 3 clinical study of Bimekizumab for the treatment of psoriasis. Also, the escalation in applications of existing biologics for rare anti-inflammatory diseases such as lupus, diffuse systemic sclerosis, and others will enhance business scenarios of the market

To get to know more about the short-term and long-term impact of COVID-19 on this market,
Please Visit: https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733
Regional Analysis:

Increasing Cases of Inflammatory Diseases to Boost Growth in North America

The market in North America stood at USD 28.63 billion in 2019. The growth of the region is attributed to rising government support for the introduction of biosimilars in the region. The potential pipeline candidates along with demand for anti-TNF drugs will aid healthy growth of the market in the region. The increasing prevalence of rheumatoid arthritis will spur demand for the market in North America. The approval of novel drugs will favor growth in Europe in the foreseeable future. For instance, in October 2018, Mylan announced the commercial launch of Hulio, a biosimilar of adalimumab. Asia Pacific is predicted to grow rapidly during the forecast period owing to the growing geriatric population. The increasing preference for biologics for inflammatory diseases will boost the market in Asia Pacific. The Middle East and Africa is likely to rise steadily in the forthcoming years owing to the improving healthcare infrastructure and rising disposable income.

Speak To Our Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anti-inflammatory-biologics-market-102733
Key Development:

December2019: Amgen, an American multinational biopharmaceutical company headquartered in Thousand Oaks, California, introduced Avsola, a biosimilar of infliximab, after receiving approval from the USFDA.

July 2017: Janssen Biotech, a biotechnology company and also subsidiary of Johnson & Johnson announced that it has received the FDA approval for Tremfyain the treatment of plaque psoriasis.

The Report Lists the Prominent Players in the Anti-Inflammatory Biologics Market

• AbbVie Inc.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Pfizer Inc.
• Novartis AG
• UCB S.A.
• Eli Lilly and Company
• Amgen Inc.
• Biogen

Quick Buy - Anti-Inflammatory Biologics Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/102733

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
LinkedIn: https://www.linkedin.com/company/fortune-business-insights
Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Inflammatory Biologics Market to Register a CAGR of 11.0% till 2027; Increasing Prevalence of Rheumatoid Arthritis to Create Sales Opportunities, states Fortune Business Insights™ here

News-ID: 2591647 • Views: 186

More Releases from Fortune Business Insights

Industry 4.0 Market to Exhibit a Remarkable CAGR of 16.3% by 2029 | Top Key Play …
Fortune Business Insights Published the Latest Industry 4.0 Market 2023 Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the Industry 4.0 Market study considers important factors such as an analysis of the market, a definition of the market, segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. The research provides an idea about
Construction Equipment Market to Exhibit a Remarkable CAGR of 6.6% by 2028 | Top …
Fortune Business Insights Published the Latest Construction Equipment Market 2023 Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the Construction Equipment Market study considers important factors such as an analysis of the market, a definition of the market, segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. The research provides an idea
Portable Toilet Market to Exhibit a Remarkable CAGR of 7.1% by 2028 | Top Key Pl …
Fortune Business Insights Published the Latest Portable Toilet Market 2023 Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the Portable Toilet Market study considers important factors such as an analysis of the market, a definition of the market, segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. The research provides an idea
Elevator and Escalator Market to Exhibit a Remarkable CAGR of 6.7% by 2029 | Top …
Fortune Business Insights Published the Latest Elevator and Escalator Market 2023 Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the Elevator and Escalator Market study considers important factors such as an analysis of the market, a definition of the market, segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. The research provides

All 5 Releases


More Releases for Inflammatory

Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant
Inflammatory Marker Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Inflammatory Marker Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Inflammatory Marker market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period. Get the sample
Digital Landscape: Inflammatory Bowel Disease Market
The Digital Landscape Inflammatory Bowel Disease market report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2 …
ReportsWorldwide has announced the addition of a new report title Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2017, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) pipeline landscape. Chronic inflammatory demyelinating polyneuropathy (CIDP) also called as
Research Offers 10-Year Forecast on Inflammatory Diseases Market
A new understanding of inflammatory diseases has changed the drug development landscape for several major diseases that are affecting millions of people in the world. Inflammation describes the primary response of the body that eliminates the cause of injury. Periodically, body’s defense mechanism works inappropriately that leads to inflammation. Drug development has focused on treating each disease symptoms separately. The discovery of drugs to treat inflammatory diseases related with immune